Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of the Efficacy of Venlafaxine and Naltrexone for Relapse Prevention in Patients With Opioid Use Disorder Attributed to Tramadol

NCT05569031 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05569031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05569031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of the Efficacy of Venlafaxine and Naltrexone for Relapse Prevention in Patients With Opioid Use Disorder Attributed to Tramadol
Lead sponsor
Zagazig University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2019
Completion date
June 15, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate withdrawal syndrome